Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
Baxter
Colorcon
QuintilesIMS
Express Scripts
UBS
Federal Trade Commission
Boehringer Ingelheim
Citi

Generated: April 26, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 013055

« Back to Dashboard

NDA 013055 describes NORFLEX, which is a drug marketed by Teligent and Medicis and is included in two NDAs. Additional details are available on the NORFLEX profile page.

The generic ingredient in NORFLEX is orphenadrine citrate. There are nine drug master file entries for this compound. Thirty-one suppliers are listed for this compound. Additional details are available on the orphenadrine citrate profile page.
Summary for 013055
Tradename:NORFLEX
Applicant:Teligent
Ingredient:orphenadrine citrate
Patents:0
Therapeutic Class:Skeletal Muscle Relaxants
Formulation / Manufacturing:see details

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:INJECTABLE;INJECTIONStrength30MG/ML
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Merck
Covington
Chinese Patent Office
Deloitte
Daiichi Sankyo
Dow
Harvard Business School
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.